Stocks
Iovance Biotherapeutics (IOVA) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -62.6% | -39.2% | -52.7% | -78.0% | -76.0% | -53.0% | ||
| Changes by years, y/y, % | -36pp | +23pp | -14pp | -25pp | +2pp | +23.4% | |||
Iovance Biotherapeutics. ROE, %
Iovance Biotherapeutics. ROE, changes, pp
Iovance Biotherapeutics (IOVA) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | -63.2% | -75.4% | -66.1% | -57.3% | -53.0% | -53.0% | |
| Changes by years, y/y, % | +35pp | +3pp | -6pp | +14pp | +10pp | |||
| Changes by quarters, q/q, % | +8pp | -12pp | +9pp | +9pp | +4pp | |||
